NasdaqGS:ANABBiotechs
Is AnaptysBio’s (ANAB) Index Exit and Office Sublease Quietly Reframing Its Strategic Focus?
In late June 2026, AnaptysBio, Inc. was removed from the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth benchmark indices, while also entering a one-year sublease agreement to rent out its San Diego facility to First Tracks Biotherapeutics.
This combination of index deletions and the move to sublease a significant amount of office space highlights shifting index representation alongside efforts to optimize AnaptysBio’s real estate commitments.
With...